Nephros (STU:NPJP) Cyclically Adjusted FCF per Share: €-0.24 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:NPJP Nephros Inc STU:NPJP
60 GF Score
Price €3.78
GF Value €2.77
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Nephros Cyclically Adjusted FCF per Share?

Nephros STU:NPJP -7.35% 60 Cyclically Adjusted FCF per Share is €-0.24 as of Jun. 2026. GuruFocus rates STU:NPJP with a GF Score™ of 60/100 and a GF Value™ of €2.77 (Significantly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Nephros's adjusted free cash flow per share for the three months ended in Jun. 2026 was €0.053. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.24 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 27.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 21.70% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 35.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Nephros was 56.00% per year. The lowest was 19.30% per year. And the median was 30.85% per year.

As of today (2026-08-21), Nephros's current stock price is €3.78. Nephros's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was €-0.24. Nephros's Cyclically Adjusted Price-to-FCF of today is .


Nephros  (STU:NPJP) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Nephros Cyclically Adjusted FCF per Share Related Terms


Nephros Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Nephros's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nephros Cyclically Adjusted FCF per Share Chart

Nephros Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.39 -0.24

Nephros Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.30 -0.26 -0.24 -0.25 -0.24

STU:NPJP vs MLSS, POCI, HBIO: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Nephros's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nephros Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nephros's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Nephros's Cyclically Adjusted Price-to-FCF falls into.


STU:NPJP
60GF Score
Nephros Inc STU:NPJP
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nephros Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nephros's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.053/333.9520*333.9520
=0.053

Current CPI (Jun. 2026) = 333.9520.

Nephros Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.131 241.428 -0.181
201612 -0.092 241.432 -0.127
201703 -0.112 243.801 -0.153
201706 -0.075 244.955 -0.102
201709 -0.099 246.819 -0.134
201712 0.251 246.524 0.340
201803 -0.088 249.554 -0.118
201806 -0.164 251.989 -0.217
201809 -0.135 252.439 -0.179
201812 -0.065 251.233 -0.086
201903 -0.087 254.202 -0.114
201906 -0.159 256.143 -0.207
201909 -0.072 256.759 -0.094
201912 0.041 256.974 0.053
202003 -0.194 258.115 -0.251
202006 -0.170 257.797 -0.220
202009 -0.171 260.280 -0.219
202012 -0.129 260.474 -0.165
202103 -0.007 264.877 -0.009
202106 -0.010 271.696 -0.012
202109 -0.078 274.310 -0.095
202112 -0.029 278.802 -0.035
202203 -0.163 287.504 -0.189
202206 -0.108 296.311 -0.122
202209 -0.017 296.808 -0.019
202212 -0.018 296.797 -0.020
202303 0.025 301.836 0.028
202306 0.020 305.109 0.022
202309 0.050 307.789 0.054
202312 -0.021 306.746 -0.023
202403 -0.059 312.332 -0.063
202406 -0.044 314.175 -0.047
202409 -0.053 315.301 -0.056
202412 0.115 315.605 0.122
202503 0.028 319.799 0.029
202506 0.080 322.561 0.083
202509 0.008 324.800 0.008
202512 0.017 324.054 0.018
202603 -0.131 330.213 -0.132
202606 0.053 333.952 0.053

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.24 mean?
Nephros (STU:NPJP) has a Cyclically Adjusted FCF per Share of €-0.24 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Nephros and its competitors.
Is Nephros' Cyclically Adjusted FCF per Share too high?
Nephros' current Cyclically Adjusted FCF per Share is €-0.24. Overall, Nephros has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nephros' Cyclically Adjusted FCF per Share compare to MLSS and POCI?
Nephros' Cyclically Adjusted FCF per Share of €-0.24 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Nephros and its competitors. Nephros's current Cyclically Adjusted FCF per Share is €-0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephros stock overvalued right now?
Based on GuruFocus' analysis, Nephros (STU:NPJP) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.77, compared to a current price of €3.78 — trading 36.5% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €-0.24. Nephros' overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Nephros (STU:NPJP), the current Cyclically Adjusted FCF per Share is €-0.24 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nephros (STU:NPJP) Overvalued in 2026?

Based on GuruFocus' analysis, Nephros stock appears to be overvalued. The current stock price of €3.78 is trading 36.5% above its estimated GF Value™ of €2.77. GuruFocus considers Nephros to be Significantly Overvalued.

Key valuation signals for STU:NPJP:

  • Cyclically Adjusted FCF per Share: €-0.24
  • GF Value™: €2.77 vs. price of €3.78 (36.5% above fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the STU:NPJP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nephros Business Description

Other Exchanges NEPH:USA
Address 380 Lackawanna Place, South Orange, NJ, USA, 07079
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
60GF Score

Get the complete analysis for STU:NPJP

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.78
Price
€2.77
GF Value